date:Mar 25, 2014
t performing exactly as the original biocatalyst. Following the successful parallel runs the production was scaled-up to routine production and validated in a series of 3 production runs, all of which yielded usable product for the customer.
Within 6 months Biocatalysts completed the project, moving from the initial stages of process redesign and confirmation right through to routine enzyme production. The reliable supply of this enzyme at the required scale meant the customer could benefit fro